Mei et al. [25], Jia et al. [24], Rios et al. [28], and Liu et al. [29] employed machine learning models for predicting the mutational status of EGFR in patients affected by lung adenocarcinoma, using a different publicly available dataset than ours. The gene discussed is EGFR; the disease is lung adenocarcinoma.